Inpharma Weekly

, Volume 1573, Issue 1, pp 15–16 | Cite as

Dasatinib: a once-daily option for imatinib-resistant CML

Meeting report
  • 4 Downloads

Keywords

Imatinib Chronic Myeloid Leukaemia Dasatinib Chronic Myeloid Leukaemia Patient Cytogenetic Response 

Copyright information

© Adis International Ltd 2007

Personalised recommendations